AdvanDx

More stories

• Test cuts hospital death rates by 42%

  AdvanDx24 October 2008

  A study has demonstrated the use of AdvanDX's PNA Fish test to reduce mortality by 42 per cent for patients with drug resistant hospital-acquired enterococcus faecium bloodstream infections (BSIs).

• AdvanDX receives clearance for yeast traffic light

  AdvanDx26 September 2008

  AdvanDX has received FDA 510(k) clearance for its Yeast Traffic Light PNA Fish to identify Candida yeast species directly from positive blood cultures.

• PNA Fish for bloodstream infection diagnoses

  AdvanDx8 August 2008

  Dartmouth-Hitchcock medical centre implements AdvanDx's PNA Fish tests to improve diagnoses and care for patients with bloodstream infections

• Diagnostic test can reduce death in IC units

  AdvanDx16 July 2008

  Study shows use of AdvanDx's PNA Fish test was associated with an 82% reduction in intensive care unit mortality rates from staphylococcus aureus bloodstream infections

• Yeast Traffic Light submitted for FDA clearance

  AdvanDx4 June 2008

  AdvanDx has announced the FDA 510(k) submission of Yeast Traffic Light PNA Fish for detection of Candida yeast species from positive blood cultures

More like this